Skip to content
Abierto
Menu

Award notice, first published as presolicitation

Rituximab Effective 09/15/2025 - 09/14/2026

36E79725R0021

Department of Veterans Affairs, Nac Pharmaceuticals. Pharmaceutical Preparation Manufacturing.

View on SAM.govMarkdown

Awarded

Pfizer Inc.

$0.00 obligated so far on USAspending

Description

As published on SAM.gov with the solicitation of February 13, 2025.

Rituximab

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

Recipient
Pfizer Inc.
UEI
MHBQULRMEEJ5
CAGE
86491
Vendor location
New York, NY
Contract
36E79725D0032
Obligated
$0.00, potential $74,038,217
Actions
5 between April 29, 2025 and September 2, 2026
Competition
Full and Open Competition, 2 offers received
Set-aside reported
No Set Aside Used.
Described as
New Award for Rituximab with Pfizer INC. Base Year Ordering Period Is September 15, 2025 to September 14, 2026 with Four ONE-YEAR Options.
Match
award number 36E79725D0032 equals the contract number; same awarding office 36E797 (high confidence)
Record
USAspending award page

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. January 28, 2025

    Presolicitation

    Rituximab and Biosimilars

    Due February 14, 2025 at 3:30 PM EST. SAM.gov, notice f54810a5b77f424297b8eb9d6097413f

  2. February 10, 2025

    Solicitation, originally presolicitation

    Rituximab and Biosimilars

    Due March 4, 2025 at 3:30 PM EST. SAM.gov, notice cd8e8fc27b3f41d39462038592416ea1

  3. February 13, 2025

    Solicitation

    Rituximab and Biosimilars

    Due March 11, 2025 at 3:30 AM EDT. SAM.gov, notice 60656e591de34a70a8ec8be73cd36547

  4. April 29, 2025

    Award notice

    Awarded to Pfizer Inc. New York 10001 for $74,038,217. SAM.gov, notice bf70e13c1f034cf3af08f4cc0609fd75

Points of contact

Also open from this buyer